Annual studies of influenza vaccine effectiveness: Evaluating performance, informing policy, and generating new questions

Clinical Infectious Diseases

Volumn 58, Issue 3, 2014, Pages 328-329

  Neuzil, Kathleen M ^a,b,c   Victor, John C ^a  

^a PATH   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

case control study; effectiveness; influenza vaccine; vaccine policy

Indexed keywords

INACTIVATED VACCINE; INFLUENZA VACCINE; LIVE VACCINE;

CLINICAL EFFECTIVENESS; HEALTH CARE POLICY; HELP SEEKING BEHAVIOR; HEMAGGLUTINATION INHIBITION TEST; HUMAN; INFLUENZA; INFLUENZA B; INFLUENZA VACCINATION; NOTE; PRIORITY JOURNAL;

CASE-CONTROL STUDY; EFFECTIVENESS; INFLUENZA VACCINE; VACCINE POLICY;

FEMALE; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; VACCINATION;

EID: 84892771128     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit739     Document Type: Note

References (11)

1. Girard MP, Tam JS, Pervikov Y, et al. Report on the first WHO integrated meeting on development and clinical trials of influenza vaccines that induce broadly protective and long-lasting immune responses: Hong Kong SAR, China, 24-26 January 2013. Vaccine 2013; 31:3766-71.
2. Osterholm MT, Kelley NS, Sommer A, et al. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2012; 12:36-44.
3. McElhaney JE, Coler RN, Baldwin SL. Immunologic correlates of protection and potential role for adjuvants to improve influenza vaccines in older adults. Expert Rev Vaccines 2013; 12:759-66.
4. Influenza Division, National Center for Immunization and Respiratory Diseases, CDC. Prevention and control of seasonal influenza with vaccines. MMWR 2013; 62:1-43.
5. Matthews JT. Egg-based production of influenza vaccines: 30 years of commercial experience. The Bridge 2006; 36:17-24.
6. Ohmit SE, Thompson MG, Petrie JG, et al. Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. Clin Infect Dis 2014; 58: 319-27.
7. Foppa IM, Haber M, Ferdinands JM, et al. The case test-negative design for studies of the effectiveness of influenza vaccine. Vaccine 2013; 31:3104-9.
8. Neuzil KM, Englund JA. Influenza vaccine for young children: two doses are better than one. J Pediatr 2006; 149:737-8.
9. Vesikari T, Knuf M, Wutzler P, et al. Oil-in-water emulsion adjuvant with influenza vaccine in young children. N Engl J Med 2011; 365:1406-16.
10. Neuzil KM, Jackson LA, Nelson J, et al. Im-munogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children. J Infect Dis 2006; 194:1032-9.
11. Ohmit SE, Petrie JG, Malosh RE, et al. Influenza vaccine effectiveness in the community and the household. Clin Infect Dis 2013; 56:1363-9.